Labrucherie Gil M

CIK 00013948754 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001394875

Recent Transactions

50 trades

Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2026-02-06+125,000→ 125,000 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2025-11-19+12,000→ 12,000 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-11-19+21,000→ 55,500 total
Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2025-08-07+37,500→ 37,500 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-06-10+9,000→ 34,500 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2025-06-10+5,000→ 5,000 total
Purchase
Septerna, Inc.$SEPN
Common Stock
2025-02-27$5.85/sh+3,718→ 40,000 total
Purchase
Septerna, Inc.$SEPN
Common Stock
2025-02-25$5.59/sh+6,282→ 36,282 total
Purchase
Septerna, Inc.$SEPN
Common Stock
2025-02-21$5.85/sh+5,000→ 30,000 total
Purchase
Septerna, Inc.$SEPN
Common Stock
2025-02-20$5.88/sh+14,500→ 25,000 total
Purchase
Septerna, Inc.$SEPN
Common Stock
2025-02-19$5.51/sh+10,500→ 10,500 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2025-02-16+15,000→ 15,000 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-02-16+25,500→ 25,500 total
Award
Septerna, Inc.$SEPN
Stock Option (Right to Buy)
2025-02-07+222,000→ 222,000 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2024-08-31+150,000→ 150,000 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2024-05-23+184,042→ 184,042 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2024-01-23+30,000→ 30,000 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2024-01-09+855,513→ 855,513 total
Other
ACELYRIN, Inc.
Common Stock
2023-10-04+40,763→ 40,763 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-08-17+254,939→ 254,939 total
Award
Rezolute, Inc.$RZLT
Stock Option (right to buy)
2022-06-23+80,000→ 80,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-05-16$3.95/sh−17,448→ 312,905 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-05-15+28,750→ 330,353 total
Purchase
Rezolute, Inc.$RZLT
Common Stock
2022-05-04$3.80/sh+52,631→ 52,631 total
Purchase
Rezolute, Inc.$RZLT
Common Stock
2022-05-04$3.80/sh+52,631→ 53,572 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-02-16$10.95/sh−7,579→ 301,603 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-12-16+52,950→ 309,182 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-12-16+94,000→ 94,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-18$12.69/sh−3,000→ 256,682 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-16$13.16/sh−21,149→ 259,682 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-15+40,150→ 280,831 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-10-12+71,550→ 71,550 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-08-17$13.56/sh−3,000→ 240,231 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-08-16$13.83/sh−7,867→ 243,231 total
Award
Rezolute, Inc.$RZLT
Stock Option (right to buy)
2021-06-14+5,000→ 5,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-05-17$18.30/sh−7,898→ 251,098 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-16$22.37/sh−7,977→ 258,996 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-02-04−50,000→ 0 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-04$8.80/sh+50,000→ 316,973 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-04$19.81/sh−50,000→ 266,973 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-02-03−25,000→ 0 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-03$8.80/sh+25,000→ 316,973 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-03$19.61/sh−50,000→ 266,973 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-03$8.80/sh+25,000→ 291,973 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-02-03−25,000→ 50,000 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-02$8.80/sh+50,000→ 316,973 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-02$21.66/sh−1,933→ 266,973 total
Exercise/Conversion
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-02-02−50,000→ 25,000 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-02$20.96/sh−6,932→ 268,906 total
Sale
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-02-02$19.97/sh−41,135→ 275,838 total

Companies

Recent Filings

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov